文献速递肝病

免疫相关GTP酶通过诱导脂噬防止肝脏脂质过度积累

Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation.
PubMed 文献 · J Hepatol · 2020-05-04

该研究通过小鼠重组同类系定位克隆,鉴定出Ifgga2和Ifgga4两个免疫相关GTP酶可防止肝脏脂质储存。肝脏特异性抑制Ifgga2或Ifgga4使肝脂肪含量增加3-4倍。IFGGA2与脂肪酶ATGL结合,可能通过增强LC3B与脂滴结合促进脂噬,从而对抗肝脂肪变性。

要点

  • Ifgga2/Ifgga4及人同源基因IRGM在脂肪肝中表达显著降低。
  • 肝脏抑制Ifgga2或Ifgga4导致肝脂肪含量增加3-4倍。
  • IFGGA2与ATGL结合并增强LC3B与脂滴关联,促进脂噬。

核心结论

  • IFGGA2与ATGL相互作用,最可能通过增强LC3B与脂滴的结合来防止肝脂肪变性。

研究设计与样本

  • 携带Ltg/NZO 5.3 Mbp片段的重组同类系小鼠接受高脂饮食并表征肝脏脂肪。
  • 通过生物信息学分析、mRNA谱和电泳迁移率变动分析鉴定负责Ltg/NZO表型的基因。
  • 通过向C57BL/6小鼠注射特定microRNA在体内操纵候选基因。
  • 采用pulldown结合质谱蛋白质组学和免疫共沉淀鉴定IFGGA2的相互作用伙伴。

主要发现

  • 通过定位克隆鉴定出两个免疫相关GTP酶Ifgga2和Ifgga4可防止肝脏脂质储存。
  • 小鼠两个基因及人同源基因IRGM在脂肪肝中表达显著降低。
  • 肝脏特异性抑制Ifgga2或Ifgga4导致肝脂肪含量增加3-4倍。
  • 低脂饮食小鼠肝脏中IFGGA2定位于内体/溶酶体,高脂饮食时与脂滴关联。
  • Pulldown实验和蛋白质组学鉴定脂肪酶ATGL为IFGGA2的结合伙伴,并经免疫共沉淀证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Currently, only a few genetic variants explain the heritability of fatty liver disease. Quantitative trait loci (QTL) analysis of mouse strains has identified the susceptibility locus Ltg/NZO (liver triglycerides from New Zealand obese [NZO] alleles) on chromosome 18 as associating with increased hepatic triglycerides. Herein, we aimed to identify genomic variants responsible for this association. METHODS: Recombinant congenic mice carrying 5.3 Mbp of Ltg/NZO were fed a high-fat diet and characterized for liver fat. Bioinformatic analysis, mRNA profiles and electrophoretic mobility shift assays were performed to identify genes responsible for the Ltg/NZO phenotype. Candidate genes were manipulated in vivo by injecting specific microRNAs into C57BL/6 mice. Pulldown coupled with mass spectrometry-based proteomics and immunoprecipitation were performed to identify interaction partners of IFGGA2. RESULTS: Through positional cloning, we identified 2 immunity-related GTPases (Ifgga2, Ifgga4) that prevent hepatic lipid storage. Expression of both murine genes and the human orthologue IRGM was significantly lower in fatty livers. Accordingly, liver-specific suppression of either Ifgga2 or Ifgga4 led to a 3-4-fold greater increase in hepatic fat content. In the liver of low-fat diet-fed mice, IFGGA2 localized to endosomes/lysosomes, while on a high-fat diet it associated with lipid droplets. Pulldown experiments and proteomics identified the lipase ATGL as a binding partner of IFGGA2 which was confirmed by co-immunoprecipitation. Both proteins partially co-localized with the autophagic marker LC3B. Ifgga2 suppression in hepatocytes reduced the amount of LC3B-II, whereas overexpression of Ifgga2 increased the association of LC3B with lipid droplets and decreased triglyceride storage. CONCLUSION: IFGGA2 interacts with ATGL and protects against hepatic steatosis, most likely by enhancing the binding of LC3B to lipid droplets. LAY SUMMARY: The genetic basis of non-alcoholic fatty liver disease remains incompletely defined. Herein, we identified members of the immunity-related GTPase family in mice and humans that act as regulators of hepatic fat accumulation, with links to autophagy. Overexpression of the gene Ifgga2 was shown to reduce hepatic lipid storage and could be a therapeutic target for the treatment of fatty liver disease.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Schwerbel K, Kamitz A, Krahmer N, et al. Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation. J Hepatol. 2020. PMID: 32376415. doi:10.1016/j.jhep.2020.04.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。